Dr. Pan-Chyr Yang presents the Taiwan national lung cancer early detection program for heavy smokers & non-smokers w/ family history at #ASCO24. Noting the different biology of lung cancer in non-smokers and the need to adapt strategies to biology and populations.

What a great #ASCO24 Lung Cancer poster walk. Thanks to Drs. Corey Langer Mihaela Aldea Monica Chen Enriqueta Felip for walking though their posters and all the tips and career advice!

Best choice EVER! Jeffrey Farma is Fox Chase Cancer Center new Chair of Surgery 😎

Honored and grateful to celebrate my promotion last night with amazing colleagues and mentors Fox Chase Cancer Center

Congratulations to our graduating fellows. A fantastic group of oncologists joining us as colleagues. All of us at Fox Chase Cancer Center are proud of you all.

Congratulations to Dr. Jessica Bauman for receive the Robert Krigel Teaching Award this year from our graduating fellows. A well deserved recognition.

Panel discussion on Her2, Her3 and NRG1 in NSCLC. Great audience questions at DAVA Oncology Thoracic Malignancies Summit.

Looking forward to chairing session at DAVA Oncology meeting on newly diagnosed lung cancer. View from podium but I won’t be tweeting during the session. Hopefully my colleagues will cover this session. Hossein Borghaei, DO Dr. Nagla Abdel Karim Patrick C. Ma, MD

Dr. Anne Chiang, Yale Cancer Center, presenting on the role of IO in SCLC, #DAVALUNG

Dr. Wheatley-Price, University of Ottawa, presenting data using the RWE from the Canadian Small Cell database. #DAVALung

Dr. Apar Ganti, Apar Kishor Ganti , discussing the role of maintenance treatment in SCLC, in particular the IMForte trial. Is there a role for Lurbinectedin in this setting?

Dr. Anne Chiang, Anne Chiang , Yale Cancer Center, discussing the SWOG PRISM study. Is it possible to address different subtypes of SCLC with different treatments.

Dr. Wade Iams, currently at Vanderbilt, reviews how to improve the sensitivity of ctDNA assays in detecting SCLC based on an investigator initiated trial.

A fantastic presentation by Dr. Parth Desai, at Fox Chase Cancer Center/Temple Health, on SCLC plasticity and micro environment changes in this disease. Data from NCI’s Rapid Biopsy Program.

Starting Now: Novel Bispecifics, ADCs, and Radiation Sensitizers in Head and Neck Cancer Moderated by: Hossein Borghaei, DO #DAVAHawaiiLung

📢New Publication Alert! 📢 Excited to share our latest review article published in #Cancer and Metastasis Reviews describing how cancer treatments impact dormant DTCs in the lung. Thank you so much and congratulations to all co-authors: #NicolasE.; Dr. Edna Cukierman, Ph.D., #KosmiderB.;

Latest IASLC podcast episode is in Farsi with guest host Dr. Hossein Borghaei, DO and guests Drs. Afshin Dowlati and Sharareh Seifi. Grateful to IASLC for engaging, educational content in many different languages. iaslc.org/iaslc-news/lun…

Join me at the 19th annual New York Lung Cancers Symposium, NY Hilton Midtown on November 16, 2024, for all the latest updates and debates, engaging discussions on challenging cases and networking! Free registration with code LIU at checkout. gotoper.com/courses/new-yo…

Lung-MAP Next Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers oncodaily.com/insight/119356… Lung-MAP SWOG Cancer Research Network National Cancer Institute Friends of Cancer Research Foundation for the National Institutes of Health Mike Wu David Gandara Hossein Borghaei, DO #Cancer #Genomics #LCSM #OncoDaily #Oncology

The Lung-MAP precision medicine trial’s S1900K sub-study randomizes patients w MET exon 14 skipping-positive advanced non-small cell #lungcancer to tepotinib w/wo ramucirumab. PI: Paul K. Paik, MD BenWellington. An ECOG-ACRIN Cancer Research Group sub-study. SWOG.org/clinical-trial… #NSCLC #lcsm